Matrix Laboratories
US drug maker Mylan looking to India as key growth hub
28 May 2011
Mylan to rename Matrix Lab as 'Mylan'
27 May 2011
Pfizer, Mylan lower HIV drug prices for drug-resistant patients
08 August 2009
After Matrix who will be delisted next?
28 March 2009
Jagdish Dore new CEO of Matrix Labs
28 February 2008
Matrix Labs may divest Docpharma
28 February 2008
Matrix Labs gets US FDA nod for HIV drug
05 December 2007
Matrix to acquire residual holding in China''s Mchem group
25 August 2007
Mylan completes stake acquisition in Matrix
10 January 2007
JB Chemicals, Matrix Labs in licensing agreement with Gilead Sciences for HIV drug
22 September 2006
Update: Generic API biz to strengthen post deal says Matrix Labs CEO
28 August 2006
Mylan Labs to acquire Matrix Labs for $736 million
28 August 2006
Matrix to acquire controlling stake in Concord Biotech
06 December 2005
Matrix acquires 43 per cent stake in Swiss firm Explora Labs
21 September 2005
Matrix Labs acquires Belgian drug firm Docpharma for $263 m
20 June 2005
Matrix Labs gets US approval for second unit
13 March 2004
Divi''s, Matrix scrip prices cross leading pharma firms'' prices
29 December 2003
Matrix to merge Vorin, Medicorp with itself
16 September 2002
 search domain-b